FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085242 [Registered on: 21/04/2025] Trial Registered Prospectively
Last Modified On: 21/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   ROLE OF INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT IN CASES OF GOUT  
Scientific Title of Study   TO STUDY THE ROLE OF INDIVIDUALIZED HOMOEOPATHIC MANAGEMENT IN CASES OF GOUT – A PROSPECTIVE INTERVENTIONAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  YASH PATIDAR 
Designation  PG SCHOLAR 
Affiliation  JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE  
Address  ROOM NO 401 PG DEPARTMENT OF ORGANON OF MEDICINE, JAWAHARLAL HOMOEOPATHIC MEDICAL COLLEGE, PARUL UNIVERSITY, WAGHODIA, VADODARA

Vadodara
GUJARAT
391760
India 
Phone  9644160436  
Fax    
Email  patidaryash1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR MAYANK ROY 
Designation  BHMS, MD (HOM) 
Affiliation  JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE 
Address  ROOM NO 402 B DEPARTMENT OF ORGANON OF MEDICINE, JAWAHARLAL HOMOEOPATHIC MEDICAL COLLEGE, PARUL UNIVERSITY, WAGHODIA, VADODARA

Vadodara
GUJARAT
391760
India 
Phone  7405002111  
Fax    
Email  Dr.mayankroy@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR MAYANK ROY 
Designation  BHMS, MD (HOM) 
Affiliation  JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE 
Address  ROOM NO 402 B DEPARTMENT OF ORGANON OF MEDICINE, JAWAHARLAL HOMOEOPATHIC MEDICAL COLLEGE, PARUL UNIVERSITY, WAGHODIA, VADODARA

Vadodara
GUJARAT
391760
India 
Phone  7405002111  
Fax    
Email  Dr.mayankroy@gmail.com  
 
Source of Monetary or Material Support  
JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE, PARUL UNIVERSITY, LIMDA, WAGHODIA VADODARA, 391760  
 
Primary Sponsor  
Name  YASH PATIDAR 
Address  JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL, PARUL UNIVERSITY, WAGHODIA, VADODARA, GUJARAT, 391760  
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR YASH PATIDAR  JAWAHARLAL NEHRU HOMOEOPATHIC HOSPITAL   OPD NO 110, DEPARTMENT OF ORGANON OF MEDICINE
Vadodara
GUJARAT 
9644160436

patidaryash1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE (INSTITUTIONAL ETHICS COMMITTEE FOR HUMAN RESEARCH)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M109||Gout, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  INDIVIDUALIZED HOMOEOPATHIC MEDICINES  INDIVIDUALIZED HOMOEOPATHIC MEDICINES WILL BE USED IN SELECTIVE POTENCY, AS IN REQUIRED REPETITION FOR 15 DAYS 
Comparator Agent  NOT APPLICABLE  NOT APPLICABLE 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  78.00 Year(s)
Gender  Both 
Details  1.Patient between the ages of 18 to 78.
2.Patients suffering from chronic gout with high UA levels (27 mg/dL)
3.The gout had to be clinically apparent, with symptoms such as joint pains
4.The patients giving their consent to participate in study. 
 
ExclusionCriteria 
Details  1.Pregnant and lactating women.
2.Patient with septic arthritis, trauma, renal failure.
3.Patients already undergoing treatment with other system of medicine.
4.Cases with less than 6 follow up. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.To evaluate the role of individualized homoeopathic medicine in Gout
2.To investigate the role of individualized homoeopathic medicine in reducing serum uric acid
levels in gout patients.
3.To improve the quality of life of the patients. 
3 MONTHS 
 
Secondary Outcome  
Outcome  TimePoints 
GOUT ASSESSMENT QUESTIONNARE 2.O IS USED FOR ASSESSMENT FOR GOUT.
HIGHER SCORE = WORSE CONDITION / GREATER GOUT IMPACT 
3 MONTHS 
 
Target Sample Size   Total Sample Size="55"
Sample Size from India="55" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   03/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The study is prospective interventional study the role of Individualized Homoeopathic Management in cases of Gout. The study will be conducted in 55 participants which will be enrolled in Jawaharlal Nehru Homoeopathic Medical College Hospital, Vadodara, Gujarat, India. GAQ2 will be used for assessment purpose. The study will be conducted in the time duration of 1 year.
 
Close